50-173-7015

CHCHD6 Mouse anti-Human, Clone: 2A11E9, Proteintech

Manufacturer: Proteintech Group Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-173-7015-Each-of-1 In Stock ₹ 44,150.23

50-173-7015 - Each of 1

₹ 44,150.23

In Stock

Quantity

1

Base Price: ₹ 44,150.23

GST (18%): ₹ 7,947.041

Total Price: ₹ 52,097.271

Antigen

CHCHD6

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.1% sodium azide; pH 7.3

Gene Accession No.

Q9BRQ6

Gene Symbols

CHCHD6

Immunogen

CHCHD6 Fusion Protein Ag14700

Quantity

150 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2a

Applications

Western Blot

Clone

2A11E9

Conjugate

Unconjugated

Gene

CHCHD6

Gene Alias

CHCHD6

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

84303

Content And Storage

-20°C

Form

Liquid

Related Products

Img

Proteintech Group Inc

50-173-7133

--

Img

Bioss

50-197-9914

--

Img

Proteintech Group Inc

50-173-6874

--

Img

Proteintech Group Inc

50-173-6690

--

Img

Proteintech Group Inc

50-233-2618

--

Img

Proteintech Group Inc

50-172-7407

--

Img

Proteintech Group Inc

50-172-7321

--

Img

Proteintech Group Inc

50-173-7169

--

Description

  • CHCHD6 is a member of a family of proteins containing a conserved (coiled coil 1)-(helix 1)-(coiled coil 2)-(helix 2) domain and has been observed in a complex with the mitochondrial proteins mitofilin, SAM50, metaxins 1 and 2, and CHCHD3
  • CHCHD6 knockdown causes severe defects in mitochondrial cristae morphology as well as reductions in cell growth, ATP production and oxygen consumption
  • This decrease of CHCHD6 also led to a reduction in mitofilin protein levels, while a knockdown of mitofilin resulted in a reduced level of CHCHD6, suggesting coordinate regulation between these two proteins
  • CHCHD6 knockdown in human cancer cells enhances their sensitivity to genotoxic anticancer drugs, suggesting that CHCHD6 may be a potential therapeutic anti-tumor target.